Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever

Update Il y a 4 ans
Reference: NCT01601613

Woman and Man

Extract

This trial is conducted in Asia. The aim of this is to investigate the efficacy and safety of activated recombinant human factor VII (rFVIIa) in achieving haemostasis in patients with Dengue haemorrhagic fever (DHF).


Inclusion criteria

  • Acquired Bleeding Disorder ,Dengue Haemorrhagic Fever

Links